The reported statements, read against the company's own industry.
Financials view
Market Capitalization
264.87MGBP
347.44M · vs all stocks (USD)
Updated Oct 25, 2026
Trailing P/E
121.75x
vs Health Information Services peers
Updated Oct 25, 2026
Revenue (TTM)
120.64MGBP
158.25M · vs all stocks (USD)
Updated Oct 25, 2026
Profit Margin
1.16%
vs Health Information Services peers
Updated Oct 25, 2026
Beta
0.2800x
vs all stocks
Updated Oct 25, 2026
52-Week Change
26.49%
vs all stocks
Updated Oct 25, 2026
Forward Annual Dividend Yield
0.00%
vs all stocks
Updated Oct 25, 2026
Market Capitalization
264.87MGBP
347.44M · vs all stocks (USD)
Updated Oct 25, 2026
Enterprise Value
368.23MGBP
483.03M · vs all stocks (USD)
Updated Oct 25, 2026
Trailing P/E
121.75x
vs Health Information Services peers
Updated Oct 25, 2026
Forward P/E
13.71x
vs Health Information Services peers
Updated Oct 25, 2026
Price to Sales (TTM)
2.20x
vs Health Information Services peers
Updated Oct 25, 2026
Price to Book (MRQ)
1.27x
vs Health Information Services peers
Updated Oct 25, 2026
Enterprise to Revenue
3.05x
vs Health Information Services peers
Updated Oct 25, 2026
Enterprise to EBITDA
35.90x
vs Health Information Services peers
Provider-reported. Enterprise Value ÷ EBITDA (TTM) on this page gives 24.18×.Updated Oct 25, 2026
Profit Margin
1.16%
vs Health Information Services peers
Updated Oct 25, 2026
Operating Margin
2.26%
vs Health Information Services peers
Updated Oct 25, 2026
Return on Assets (TTM)
0.86%
vs Health Information Services peers
Updated Oct 25, 2026
Return on Equity (TTM)
0.83%
vs Health Information Services peers
Updated Oct 25, 2026
Revenue (TTM)
120.64MGBP
158.25M · vs all stocks (USD)
Updated Oct 25, 2026
Revenue per Share (TTM)
1.35GBPUpdated Oct 25, 2026
Quarterly Revenue Growth
12.70%
vs Health Information Services peers
Updated Oct 25, 2026
Gross Profit (TTM)
35.38MGBP
46.41M · vs all stocks (USD)
Updated Oct 25, 2026
EBITDA (TTM)
15.23MGBP
19.98M · vs all stocks (USD)
Updated Oct 25, 2026
Net Income (TTM)
1.40MGBP
1.84M · vs all stocks (USD)
Updated Oct 25, 2026
Quarterly Earnings Growth (YoY)
-91.40%
vs Health Information Services peers
Updated Oct 25, 2026
Operating Cash Flow (TTM)
15.24MGBP
19.99M · vs all stocks (USD)
Updated Oct 25, 2026
Levered Free Cash Flow (TTM)
18.00MGBP
23.61M · vs all stocks (USD)
Updated Oct 25, 2026
Forward Annual Dividend Yield
0.00%
vs all stocks
Updated Oct 25, 2026
Trailing Annual Dividend Rate
0.00GBPUpdated Oct 25, 2026
Trailing Annual Dividend Yield
0.00%
vs all stocks
Updated Oct 25, 2026
Payout Ratio
0.00%
vs Health Information Services peers
Updated Oct 25, 2026
Revenue
120.64MGBPFY2026 · Mar 31, 2026
Cost of Goods Sold
85.26MGBPFY2026 · Mar 31, 2026
Gross Profit
35.38MGBPFY2026 · Mar 31, 2026
Operating Income
3.97MGBP
5.21M · vs all stocks (USD)
FY2026 · Mar 31, 2026
Pre-tax Income
2.47MGBPFY2026 · Mar 31, 2026
Income Tax Expense
1.07MGBPFY2026 · Mar 31, 2026
Net Income
1.40MGBPFY2026 · Mar 31, 2026
EBIT
4.03MGBPFY2026 · Mar 31, 2026
EBITDA (Income Statement)
15.23MGBPFY2026 · Mar 31, 2026
Selling, General & Administrative
24.41MGBPFY2026 · Mar 31, 2026
Non-operating Interest Income
55.00KGBPFY2026 · Mar 31, 2026
Non-operating Interest Expense
1.56MGBPFY2026 · Mar 31, 2026
EPS (Basic)
0.0199GBPFY2026 · Mar 31, 2026
EPS (Diluted)
0.0199GBPFY2026 · Mar 31, 2026
Basic Shares Outstanding
89.69MSharesFY2026 · Mar 31, 2026
Diluted Shares Outstanding
89.69MSharesFY2026 · Mar 31, 2026
Preferred Stock Dividends
0.00GBPFY2026 · Mar 31, 2026
Operating Cash Flow
15.24MGBPFY2026 · Mar 31, 2026
Cash & Cash Equivalents (End of Period)
21.61MGBPFY2026 · Mar 31, 2026
Starting Profit (CF Statement)
2.47MGBPFY2026 · Mar 31, 2026
Stock-based Compensation
242.00KGBPFY2026 · Mar 31, 2026
Other Non-cash Items
1.51MGBPFY2026 · Mar 31, 2026
Change in Accounts Receivable (CF)
-1.85MGBPFY2026 · Mar 31, 2026
Change in Other Assets/Liabilities
-48.00KGBPFY2026 · Mar 31, 2026
Net Intangibles (CF)
-2.04MGBPFY2026 · Mar 31, 2026
Net Acquisitions
-101.81MGBPFY2026 · Mar 31, 2026
Net Investing Cash Flow
-101.81MGBPFY2026 · Mar 31, 2026
Long-term Debt Issuance
69.00MGBPFY2026 · Mar 31, 2026
Net Short-term Debt Issuance
30.00MGBPFY2026 · Mar 31, 2026
Net Financing Cash Flow
99.00MGBPFY2026 · Mar 31, 2026
Shares Outstanding
89.23MSharesUpdated Oct 25, 2026
Float Shares
64.11MSharesUpdated Oct 25, 2026
% Held by Insiders
29.24%
vs all stocks
Updated Oct 25, 2026
% Held by Institutions
46.24%
vs all stocks
Updated Oct 25, 2026
Total Cash (MRQ)
21.61MGBP
28.34M · vs all stocks (USD)
Updated Oct 25, 2026
Total Cash per Share (MRQ)
0.1990GBPUpdated Oct 25, 2026
Total Debt (MRQ)
124.97MGBP
163.93M · vs all stocks (USD)
Updated Oct 25, 2026
Total Debt to Equity (MRQ)
0.7361x
vs Health Information Services peers
Updated Oct 25, 2026
Current Ratio (MRQ)
0.8440x
vs Health Information Services peers
Updated Oct 25, 2026
Book Value per Share (MRQ)
1.91GBPUpdated Oct 25, 2026
Total Assets
356.02MGBP
467.01M · vs all stocks (USD)
FY2026 · Mar 31, 2026
Total Current Assets
56.71MGBPFY2026 · Mar 31, 2026
Total Liabilities
186.24MGBPFY2026 · Mar 31, 2026
Total Non-current Assets
299.31MGBPFY2026 · Mar 31, 2026
Total Non-current Liabilities
119.09MGBPFY2026 · Mar 31, 2026
Total Current Liabilities
67.15MGBPFY2026 · Mar 31, 2026
Cash
21.61MGBPFY2026 · Mar 31, 2026
Cash & Cash Equivalents
21.61MGBPFY2026 · Mar 31, 2026
Accounts Receivable
18.31MGBPFY2026 · Mar 31, 2026
Inventory
397.00KGBPFY2026 · Mar 31, 2026
Accounts Payable
5.80MGBPFY2026 · Mar 31, 2026
Short-term Debt
31.35MGBPFY2026 · Mar 31, 2026
Long-term Debt
93.61MGBPFY2026 · Mar 31, 2026
Common Stock (Book)
888.00KGBPFY2026 · Mar 31, 2026
Retained Earnings
3.20MGBPFY2026 · Mar 31, 2026
Total Shareholders' Equity
169.78MGBP
222.71M · vs all stocks (USD)
FY2026 · Mar 31, 2026
52-Week Low
177.00GBXUpdated Oct 25, 2026
52-Week High
256.00GBXUpdated Oct 25, 2026
52-Week Change
26.49%
vs all stocks
Updated Oct 25, 2026
Beta
0.2800x
vs all stocks
Updated Oct 25, 2026
50-Day MA
243.47GBXUpdated Oct 25, 2026
200-Day MA
208.46GBXUpdated Oct 25, 2026
Avg 10-Day Volume
161.80KSharesUpdated Oct 25, 2026
Avg 30-Day Volume
131.96KSharesUpdated Oct 25, 2026
Diluted EPS (TTM)
0.0200GBPUpdated Oct 25, 2026
2 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Equity looks heavy for the industry, but much of it is goodwill from past acquisitions.
Reads
How does this company use capital?
Three Turnover Ratios Elevated
Collects fast, clears inventory fast, and pays suppliers fast too.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.